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Authors should submit three (3) hardcopies of their paper although
wherever possible, electronic manuscripts only may be submitted in
double-spaced typing, by E-Mail as an attachment in Word with the
tables, figures and illustrations in Word, PowerPoint or as JPEG files.
Whether hard copy or electronic it is important that the paper is
accompanied by a letter/E-Mail message indicating the name,
address, phone number, fax number, and E-Mail of the corresponding
author and a statement that all authors have contributed to, and
read, the paper and have given permission for their name to be
included as a co-author. The letter/E-Mail must also confirm that the
manuscript has not been published and will not be submitted simul-
taneously or published elsewhere. If any illustrations, diagram or part
of the text have been published elsewhere the source must be given
in full, permission by having been granted by the author and the pub-
lisher. A separate covering letter, signed by the corresponding author
on behalf of all the named authors, affirming their contribution to and
responsibility for the paper, should also be sent by regular mail or fax.
When a manuscript is accepted we require a hard copy and elec-
tronic version which must match the hard copy exactly. Always
keep a backup copy of the electronic file for reference and safety.
Label storage media with your name, journal title, and software
used. Save your files using the default extension of the program
used. The text should be in single-column format. Keep the layout
of the text as simple as possible. Most formatting codes will be
removed and replaced on processing the article. In particular, do
not use the wordprocessor’s options to justify text or to hyphenate
words. However, do use bold face, italics, subscripts, superscripts
etc. Do not embed ‘graphically designed’ equations or tables, but
prepare these using the wordprocessor’s facility. When preparing
tables, if you are using a table grid, use only one grid for each indi-
vidual table and not a grid for each row. If no grid is used, use tabs,
not spaces, to align columns. The electronic text should be pre-
pared in a way very similar to that of conventional manuscripts (see
also the Author Gateway’s Quickguide: http://authors.elsevier.com).
Do not import the figures into the text file but, instead, indicate
their approximate locations directly in the  electronic text and on
the manuscript. To avoid unnecessary errors you are strongly
advised to use the ‘spellchecker’ function of your wordprocessor.
No changes to the accepted version are permissible without 
the explicit approval of the Editor. Electronic files can be stored on
31/2 inch diskette, ZIP-disk or CD (either MS-DOS or Macintosh).
The Editor reserves the right to make editorial and literary
 corrections. No major alterations or corrections will be made
 without the knowledge and consent of the author.
All clinical studies should contain within the text of each
 manuscript a statement that all experimental protocols have 
been approved by the Ethical Committee of the Institution. 
All patients, or their guardians, must have given their consent 
after they have received appropriate information. In the case 
of experimental  animal studies, similar Ethical Committee approval
of the protocols must have been obtained before the start of the
studies.
Authors are encouraged to write concisely and the text should
read easily. Unnecessary experimental detail should be avoided,
but appropriate references should be given. All abbreviations
should be spelled out in full the first time they are mentioned. For
drugs and chemicals, the generic name should be used, but trade
names may follow in brackets.
The language of the journal is English (UK), for example, haema-
tology, anaesthetic, centre, paediatric.
All manuscripts are peer-reviewed. On receipt of the first deci-
sion letter authors should send their revised manuscript within
three months in order to ensure that the scientific content of their
manuscript is timely and up to date.
Preparation of Manuscripts
Title page: The first page should be the title page, and must
include the title of the article, names, initials and appointment of
each author, name of the department(s) and institution(s) to which
the work should be attributed and name, address, phone/fax and
e-mail details of the author for correspondence and to whom
reprints should be sent. Please note that it is essential to include
the email address of the corresponding author as proofs will be
sent by email as attached PDF files.
Keywords: Include up to 10 keywords.
Abstract: The second page should carry an abstract of not more
than 200 words. It need not be formally structured, and should be
easy to read, but must include the purpose of the study, basic
 procedures, main findings and the principal conclusions.
Text: This should start on the third page, and will normally be
divided into the following sections: Introduction, Materials (or
Patients) and Methods, Results, Discussion and Conclusions, but
other descriptive headings and subheadings may be used if they are
felt to be more appropriate.
The introduction should explain the purpose of the study or inves-
tigation, the clinical relevance and the background provided by
previous research or publications in this area, and, where appro-
priate, a statement of approval by an ethics committee.
Materials (or Patients) and Methods should give details of
 inclusion and exclusion criteria for patients in clinical trials,
research methodology, systems of assessment or measurement with
appropriate references and the statistical analysis used. Any
 equipment or apparatus used should be named, along with the
 manufacturer’s name and address. Sufficient detail should be given
to allow other investigators to repeat the study. Where relevant,
tables or figures may be included to provide information more
clearly. No data should normally be presented in this section.
Results should give all the relevant data, presented in a concise
and meaningful way, with tables or figures to present data more
clearly or concisely where appropriate. In studies with well under
100 subjects, percentages should be avoided.
Discussion should consider the results and possible confounding
factors, sources of bias, weaknesses in the study, and a review of
the relevant literature, putting the results of the study in the 
context of previous work in this area.
Conclusions must be based on the results presented.
Tables: Each Table, with an appropriately brief title, should be
numbered and printed on a separate page. No vertical lines should
be used. All tables should be referred to by number in the text.
Figures: Figures must be clearly numbered. Photographic illustra-
tions should be submitted in the form of good quality prints (not
negatives or 0 slides), approximately 12 cm  18 cm (5  7). On
the back of these, on a sticky label, should be an indication of ori-
entation (Top), the figure number, running title and first author.
Figures should be limited to those considered essential. Colour
illustrations incur an additional cost to the author and should only
be used if they illustrate important points not demonstrable in
black and white. Line drawings should be professionally drawn with
lettering large enough to stand reduction. A list of legends for each
figure must be supplied on a separate sheet of the manuscript.
Figures will not be returned after publication. All illustrations
should be referred to in the text.
Preparation of electronic illustrations
Submitting your artwork in an electronic format helps us to produce
your work to the best possible standards, ensuring accuracy, clarity
and a high level of detail.
• Always supply high-quality printouts of your artwork, in case 
conversion of the electronic artwork is problematic.
• Make sure you use uniform lettering and sizing of your original
artwork.
• Save text in illustrations as ‘‘graphics’’ or enclose the font.
• Only use the following fonts in your illustrations: Arial, Courier,
Helvetica, Times, Symbol.
• Number the illustrations according to their sequence in the text.
Use a logical naming convention for your artwork files, and supply
a separate listing of the files and the software used.
• Provide all illustrations as separate files and as hardcopy printouts
on separate sheets.
• Provide captions to illustrations separately.
• Produce images near to the desired size of the printed version.
Files can be stored on 31/2 inch diskette, ZIP-disk or CD (either 
MS-DOS or Macintosh).
A detailed guide on electronic artwork is available on our website:
http://authors.elsevier.com/artwork
Colour Reproduction Submit colour illustrations as original  photographs,
high-quality computer prints or transparencies, close to the size
expected in publication, or as 35 mm slides. Polaroid colour prints
are not suitable. If, together with your accepted  article, you sub-
mit usable colour figures then Elsevier will ensure, at no addi-
tional charge, that these figures will appear in colour on the web
(e.g., ScienceDirect and other sites) regardless of whether or not
these illustrations are reproduced in colour in the printed ver-
sion. For colour reproduction in print, you will receive information
regarding the costs from Elsevier after receipt of your  accepted
article.
Please note: Because of technical complications which can arise
by converting colour figures to ‘grey scale’ (for the printed version
should you not opt for colour in print) please submit in addition
usable black and white prints corresponding to all the colour illus-
trations.
References: Authors are strongly encouraged to check the  accuracy
of each reference against its original source.
All references listed at the end of the article must be cited in the
text. The references should be listed in the Reference section in
alphabetical order and numbered in alphabetical sequence, e.g. [1]
Abbott C. [2] Bader, G. [3] Brown, T. etc. References should be
indicated in the text by numbers with square brackets, e.g. [1] or
[3,8]. Where a reference is cited more than once in the text, the
same number should be used each time. References should take the
following form:
[1] Mackay D, Wood L, Rangan A. The treatment of isolated ulnar
fractures in adults: a systematic review. Injury 2000; 31 565—73
[2] Richards RR, Corley FG. Fractures of the Shafts of the Radius and
Ulna. In: Rockwood CA Jr, Green DP, Bucholz RW, Heckman JD.
Fractures in Adults. 4th ed. Philadelphia: Lippincott 1996 869—928
[3] Rockwood CA Jr, Green DP, Bucholz RW, Heckman JD. Fractures
in Adults. 4th ed. Philadelphia: Lippincott 1996
The titles of journals should be abbreviated as in Index Medicus. If
there are four or fewer authors, they should all be listed; if there
are five or more, the first three authors should be listed, followed
by et al.
Abbreviations and units of measurement should all be in SI units
except for measurements of blood pressure where mm Hg is pre-
ferred. For more detailed recommendations authors should consult
Baron D.N. (ed.) (1977) Units Symbols and Abbreviations: A Guide
for Biological and Medical Editors and Authors, 3rd Ed. London,
Royal Society of Medicine.
Supplementary data
Elsevier now accepts electronic supplementary material to support
and enhance your scientific research. Supplementary files offer the
author additional possibilities to publish supporting applications,
movies, animation sequences, high-resolution images, background
datasets, sound clips and more. Supplementary files supplied will
be published online alongside the electronic version of your article
in Elsevier web products, including ScienceDirect: http://www. sci-
encedirect.com. In order to ensure that your submitted material is
directly usable, please ensure that data is provided in one of our
recommended file formats. Authors should submit the material in
electronic format together with the article and supply a concise
and descriptive caption for each file. For more detailed instructions
please visit our Author Gateway at http://authors.elsevier.com.
Enquiries
Authors can keep a track on the progress of their accepted article,
and set up e-mail alerts informing them of changes to their manu-
script’s status, by using the ‘‘Track a Paper’’ feature of Elsevier’s
Author Gateway http://authors.elsevier.com. For privacy, informa-
tion on each article is password-protected. The author should key
in the ‘‘Our Reference’’ code (which is in the letter of acknowl-
edgement sent by the publisher on receipt of the accepted article)
and the name of the corresponding author. In case of problems or
questions, authors may contact the Author Service Department, 
E-mail: authorsupport@elsevier.com.
Proofs
When your manuscript is received at the Publisher it is considered
to be in its final form. Proofs are not to be regarded as ‘drafts’.
One set of page proofs in PDF format will be sent by e-mail to the
corresponding author, to be checked for typesetting/editing. No
changes in, or additions to, the accepted (and subsequently edited)
manuscript will be allowed at this stage. Proofreading is solely your
responsibility.
A form with queries from the copy editor may accompany your
proofs. Please answer all queries and make any corrections or
 additions required.
The Publisher reserves the right to proceed with publication if
corrections are not communicated. Return corrections within two
working days of receipt of the proofs. Should there be no correc-
tions, please confirm this.
Elsevier will do everything possible to get your article corrected
and published as quickly and accurately as possible. In order to do
this we need your help. When you receive the (PDF) proof of your
article for correction, it is important to ensure that all of your
 corrections are sent back to us in one communication. Subsequent
corrections will not be possible, so please ensure your first sending
is complete. Note that this does not mean you have any less time
to make your corrections, just that only one set of corrections will
be accepted.
Copyright: Authors must sign the ‘Transfer of Copyright’ agree-
ment, or, where the authors work for an organisation that does not
permit such assignment, a standard licence agreement, before an
article can be published. This transfer agreement enables Elsevier
Ltd to protect the copyright material for authors, but does not
relinquish the author’s proprietary rights. The copyright transfer
covers the exclusive rights to reproduce and distribute the article,
including reprints, photographic reproductions, microfilm or the
right to adapt the article for use or in conjunction with computer
systems and programs, including reproduction or publication in
machine-readable form and incorporation in retrieval systems.
